{"summary":"Scientist with 8 years of experience in preclinical testing & validation of mechanism of action for different drug modalities (Small molecules, bispecific antibodies, ADCs, mRNA liposomal nano particles and scFVS) in oncology and immunology. In depth knowledge in cancer biology  and autoimmunity indications. \nSkilled in development of molecular biology assays, immunology assays, cancer biology assays, multi-color flow cytometry, in vivo experiments, design and synthesis of scFv based therapeutics, synthesis of liposomal nanoparticles. Underwent training in R programming and exploration of biological data using R (TCGA analysis and RNA-seq analysis).","lastName":"Muppavarapu","objectUrn":"urn:li:member:435557226","geoRegion":"Boston, Massachusetts, United States","fullName":"Bharani Muppavarapu","firstName":"Bharani","currentPositions":[{"companyName":"Bristol Myers Squibb","description":"Scientist in Discovery Immunology dept, BMS. \nDeveloped and executed immune cell assay development and in vitro testing of biologics for two projects in matrixed teams. \n- Screened bispecifics for efficacy of autoreactive immune cell depletion and toxicity in vitro. \n- Characterized human PBMC stimulation models for proliferation of specific immune subsets using multi-color flow cytometry analysis. \n- Tested effects of bispecific antibodies on cytokine secretion in vitro using MSD analysis. \n- Contributed to development of exploratory project testing effects of ADCs in autoimmune disease. \n- Developed and characterized human PBMC based models for testing efficacy of ADCs using cell-based assays.\n- Designed and executed assays for understanding bystander effects of ADCs in immune cells using multi-color flow cytometry. \n- Communicated critical decisional data to team leads through presentations\/reports.","title":"Senior Associate Scientist","companyUrnResolutionResult":{"employeeCountRange":"10001+","headquarters":{"geographicArea":"NJ","country":"United States","city":"Lawrence Township","postalCode":"08648","line1":"3401 Princeton Pike"},"website":"http:\/\/www.bms.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/bristol-myers-squibb\/","industry":"Pharmaceutical Manufacturing"},"companyUrn":"urn:li:fs_salesCompany:1773","tenureAtCompany":{"numYears":1,"numMonths":2},"startedOn":{"month":4,"year":2023}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABn2E2oBUlRyZ4RyKc8S_IUnAaZQO9e9whU,NAME_SEARCH,-_zy)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1579484239837?e=1723075200&v=beta&t=uRbgrmScSwgRgxBPUFcIGgOJkOLx-7TrIMKa8kmxfDM","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1579484239812?e=1723075200&v=beta&t=iOTMR9lF_eVxR4YTQ52bF_CM9J_YmPQk7_e03Cr-ifo","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1579484239870?e=1723075200&v=beta&t=Kt_wUZ_017zweUZyVZbakxwot14x8a6nc7ZoWM_HRzQ","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1579484239911?e=1723075200&v=beta&t=fbBQJ9Br6uAlrauXBUc1N6oF3qnUx8GXEBLSeCnuTus","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4D03AQGm4fw80AUAXg\/profile-displayphoto-shrink_"},"projects":[{"endedOn":{"month":2,"year":2019},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABn2E2oBUlRyZ4RyKc8S_IUnAaZQO9e9whU,NAME_SEARCH,-_zy)"}],"description":"Pancreatic cancer is a uniformly lethal disease with a dismal survival rate of only 9%. It is often diagnosed at advanced stages - locally advanced or distant metastasis, when the disease has already progressed. The standard of care therapy provided for patients at this stage includes a combination of chemotherapeutic agents namely gemcitabine and abraxane, which only marginally improves the survival rate. Most tumors are chemoresistant due to two important factors - Presence of intrinsically chemoresistant stem-like cancer cells that survive and proliferate following withdrawal of chemotherapy and the dense, fibrotic architecture of tumors that reduces blood vessel patency in tumors and as a result, makes tumors inaccessible to chemotherapeutic agents. \nWe are studying a chemokine signaling pathway - CXCR4-CXCL12's role in maintenance of proliferation of stem-like cancer cells and also maintenance of fibrotic networks using a novel biotherapeutic based inhibitor of CXCR4. Our overall hypothesis is that inhibition of CXCR4 in improves chemotherapy efficacy and prolongs survival in pancreatic cancer. Our goal is to introduce a novel combination chemotherapy regimen to pancreatic cancer patients in the clinic to improve therapeutic efficacy and survival.","title":"Developing novel therapeutics to reduce chemoresistance in Pancreatic cancer","startedOn":{"month":4,"year":2017}},{"endedOn":{"month":5,"year":2016},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABn2E2oBUlRyZ4RyKc8S_IUnAaZQO9e9whU,NAME_SEARCH,-_zy)"}],"description":"The goal of the project was to find drugs inhibiting pathways involved in stem cell proliferation, for the purpose of maintaining quiescence in muscle stem cells. These cells, also known as satellite stem cells are important for the repair and regeneration of muscle tissue during injury. However, little is known about how these adult stem cells, in a state of cell-cycle arrest, are able to efficiently proliferate and localize to injured tissues in crisis. Therefore, our goal was to establish an ex vivo system of stem cells on their muscle fibers and maintain these cells in a state of non-proliferation or quiescence. Our approach was to use BDM, 2-D-Butane Dionemonoxime, a known Rho\/ROCK inhibitor that arrests actin-myosin contractility and cell cycle progression in satellite cells. ","title":"Maintenance of stem cell quiescence in muscle stem cells using BDM","startedOn":{"month":12,"year":2015}},{"endedOn":{"month":9,"year":2022},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABn2E2oBUlRyZ4RyKc8S_IUnAaZQO9e9whU,NAME_SEARCH,-_zy)"}],"description":"HNF1A is an important transcription factor whose network is upregulated in cancer stem-like cells in pancreatic ductal adenocarcinoma. Genetic depletion of HNF1A results in decrease in tumor growth as well as cancer stem-like cell burden in patient derived pancreatic tumors in mouse models. Our goal is target HNF1A using an epigenetic approach, by target Bromodomain and extra terminal domain proteins (BRD) in pancreatic cancer. BRDs are epigenetic reader proteins that promote transcription of oncogenic transcription factors, including HNF1A. We hypothesize that targeting these proteins using chemical small molecule inhibitors, BET inhibitors decreases tumor growth and cancer stem-like cell burden in pancreatic tumors. \nThis study impacts how BET inhibitors, which are currently in various phases of clinical trials will be utilized to improve prognosis in pancreatic cancer","title":"Targeting HNF1A-dependent stemness and tumor growth in pancreatic cancer using BET inhibitors ","startedOn":{"month":2,"year":2019}}],"contactInfo":{},"industry":"Hospitals and Health Care","educations":[{"endedOn":{"year":2016},"degree":"Master\u2019s Degree","eduId":291579779,"fieldsOfStudy":["Biotechnology"],"schoolName":"VIT University","startedOn":{"year":2011}},{"degree":"Masters","schoolUrn":"urn:li:fs_salesSchool:6502","eduId":979561241,"school":"urn:li:fs_salesSchool:6502","fieldsOfStudy":["Cancer sciences"],"schoolName":"University at Buffalo"}],"skills":[{"numOfEndorsement":0,"name":"Primary Cell Isolation"},{"numOfEndorsement":0,"name":"Immunoassays"},{"numOfEndorsement":0,"name":"Multi-color Flow Cytometry"},{"numOfEndorsement":0,"name":"Flow Cytometry"},{"numOfEndorsement":0,"name":"Immunohistochemistry"},{"numOfEndorsement":0,"name":"Immunofluorescence"},{"numOfEndorsement":0,"name":"Mouse Models"},{"numOfEndorsement":0,"name":"Biological Data Analysis"},{"numOfEndorsement":0,"name":"Western Blotting"},{"numOfEndorsement":0,"name":"ChIP qPCR"},{"numOfEndorsement":0,"name":"qRT-PCR"},{"numOfEndorsement":0,"name":"R programming"},{"numOfEndorsement":0,"name":"Molecular Biology"},{"numOfEndorsement":0,"name":"3D cell culture"},{"numOfEndorsement":0,"name":"Mammalian Cell Culture"},{"numOfEndorsement":0,"name":"ScFv purification and development"}],"numOfConnections":577,"patents":[],"headline":"Senior Associate Scientist, Discovery Immunology","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":true,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/bharani-muppavarapu-6b6a4a101","organizations":[],"location":"Boston, Massachusetts, United States","publications":[],"positions":null,"posts":[{"createdAt":1716223260000,"insightId":"99314919-30b3-46b8-befa-f8ecbb4eac1f","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:multiPhoto:1000184925289"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":43},{"type":"PRAISE","count":6},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7198362170051440641","threadUrn":"urn:li:ugcPost:7198362170051440641","reactionsCount":50,"commentsCount":3,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7198362170051440641","message":{"attributes":[{"start":51,"length":23,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:AEsAEuAETAEHAbRAETAERAErAbRAEpAESAETAERAEzAETAErAbRAEpAESAEDAEvAEY"}}}],"text":"\u062a\u0634\u0631\u0641\u062a \u0648\u0633\u0639\u062f\u062a \u0627\u0644\u064a\u0648\u0645 \u0628\u062a\u0643\u0631\u064a\u0645\u064a \u0645\u0646 \u0642\u0628\u0644 \u0627\u0644\u0631\u0626\u064a\u0633 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a \u0644 #\u062a\u062c\u0645\u0639_\u0645\u0643\u0629_\u0627\u0644\u0645\u0643\u0631\u0645\u0629_\u0627\u0644\u0635\u062d\u064a \u0633\u0639\u0627\u062f\u0629 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u062d\u0627\u062a\u0645 \u0627\u0644\u0639\u0645\u0631\u064a \u0628\u0639\u062f \u0641\u0648\u0632\u064a \u0628\u0627\u0644\u0645\u064a\u062f\u0627\u0644\u064a\u0629 \u0627\u0644\u0630\u0647\u0628\u064a\u0629 \u0628\u0645\u0639\u0631\u0636 \u062c\u0646\u064a\u0641 \u0627\u0644\u062f\u0648\u0644\u064a \u0644\u0644\u0627\u062e\u062a\u0631\u0627\u0639\u0627\u062a \u0662\u0660\u0662\u0664."},"entityUrn":"urn:li:ugcPost:7198362170051440641"}}},{"createdAt":1713580980000,"insightId":"7f0b2402-fea6-4321-aa6a-758ba37665db","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":19},{"type":"PRAISE","count":1},{"type":"APPRECIATION","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7187279689080598528","threadUrn":"urn:li:activity:7187279689080598528","reactionsCount":21,"commentsCount":2,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7187279688598249472","message":{"attributes":[],"text":"\u0627\u0644\u062d\u0645\u062f\u0644\u0644\u0647 \u062f\u0627\u0626\u0645\u0627\u064b \u0648\u0623\u0628\u062f\u0627\u064b\n\u200f\u0628\u0643\u0644 \u0641\u062e\u0631 .. \u0648\u0641\u064a \u0625\u0646\u062c\u0627\u0632 \u0639\u0627\u0644\u0645\u064a \u062a\u0645 \u062d\u0635\u0648\u0644\u064a \u0639\u0644\u0649 \u0627\u0644\u0645\u064a\u062f\u0627\u0644\u064a\u0629 \u0627\u0644\u0630\u0647\u0628\u064a\u0629 \ud83e\udd47\u0641\u064a \u0645\u0639\u0631\u0636 \u062c\u0646\u064a\u0641 \u0627\u0644\u062f\u0648\u0644\u064a 2024 \u0644\u0644\u0627\u062e\u062a\u0631\u0627\u0639\u0627\u062a  \u0628\u0645\u0634\u0627\u0631\u0643\u0629 ( \u0661\u0660\u0660\u0660\u0645\u062e\u062a\u0631\u0639 ) \u064a\u0645\u062b\u0644\u0648\u0646 (\u0664\u0660 )\u062f\u0648\u0644\u0629 \u062d\u0648\u0644 \u0627\u0644\u0639\u0627\u0644\u0645."},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4D22AQHau2l689dTMA\/feedshare-shrink_2048_1536\/0\/1713565791257?e=1720051200&v=beta&t=9NYYQv3wgZ-qSWZIvfR4pNs1zh1n7Ea5sL5PHY_mJpI"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7187215858262237185","message":{"attributes":[{"start":22,"length":23,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:AEsAEuAETAEHAbRAETAERAErAbRAEpAESAETAERAEzAETAErAbRAEpAESAEDAEvAEY"}}},{"start":693,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:AEnAEUAEuAEpAEAAEpAEsAbRAEBAEHAEWAExAEYAEr"}}},{"start":710,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:AETAEHAEzAEEAbRAEuAEUAEYAEP"}}},{"start":721,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:AEpAEqAEsAERAEpAEz"}}},{"start":763,"length":19,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:meccahealthcluster"}}},{"start":1565,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:saudiachievements"}}},{"start":1584,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:genevaexpo"}}},{"start":1596,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:innovation"}}}],"text":"\ud83c\uddf8\ud83c\udde6\ud83d\udc9a \u0625\u0646\u062c\u0627\u0632 \u0639\u0627\u0644\u0645\u064a \u0644\u0640 #\u062a\u062c\u0645\u0639_\u0645\u0643\u0629_\u0627\u0644\u0645\u0643\u0631\u0645\u0629_\u0627\u0644\u0635\u062d\u064a \u0628\u062d\u0635\u062f \u0645\u064a\u062f\u0627\u0644\u064a\u0627\u062a \u0639\u062f\u0629 \u0641\u064a \u0645\u0639\u0631\u0636 \u062c\u0646\u064a\u0641 \u0627\u0644\u062f\u0648\u0644\u064a \u0644\u0644\u0627\u062e\u062a\u0631\u0627\u0639\u0627\u062a 2024 \ud83e\udd47\ud83e\udd48\ud83e\udd49\n\n\ud83d\udd39 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u062a\u0648\u0641\u064a\u0642 \u0633\u0631\u0627\u062c \u064a\u0628\u062a\u0643\u0631 \u062d\u0644\u064b\u0627 \u0631\u0627\u0626\u062f\u064b\u0627 \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062e\u0644\u0639 \u0627\u0644\u0645\u062a\u0643\u0631\u0631 \u0644\u0645\u0641\u0635\u0644 \u0627\u0644\u0643\u062a\u0641\u060c \u0645\u064f\u062d\u0642\u0642\u064b\u0627 \u0627\u0644\u0645\u064a\u062f\u0627\u0644\u064a\u0629 \u0627\u0644\u0630\u0647\u0628\u064a\u0629 \u0645\u0639 \u0645\u0631\u062a\u0628\u0629 \u0627\u0644\u0634\u0631\u0641. \ud83e\udd47\n\n\ud83d\udd39 \u0627\u0644\u062f\u0643\u062a\u0648\u0631\u0629 \u0645\u0631\u064a\u0645 \u062a\u0631\u0643\u0633\u062a\u0627\u0646\u064a \u062a\u0628\u0631\u0632 \u0641\u064a \u062a\u0648\u0638\u064a\u0641 \u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0646\u0627\u0646\u0648 \u0644\u0646\u0642\u0644 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0643\u064a\u0645\u0627\u0648\u064a \u0645\u0628\u0627\u0634\u0631\u0629\u064b \u0625\u0644\u0649 \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u0633\u0631\u0637\u0627\u0646\u064a\u0629\u060c \u0645\u064f\u062a\u0648\u062c\u0629 \u0628\u0627\u0644\u0630\u0647\u0628. \ud83e\udd47\n\n\ud83d\udd39 \u0627\u0644\u0623\u0633\u062a\u0627\u0630\u0629 \u0625\u0628\u062a\u0633\u0627\u0645 \u0643\u0631\u064a\u0631\u064a \u062a\u0637\u0648\u0651\u0631 \u062b\u0644\u0627\u062c\u0629 \u0630\u0643\u064a\u0629 \u0644\u0628\u0646\u0648\u0643 \u0627\u0644\u062f\u0645\u060c \u0646\u0627\u0644\u062a \u0627\u0644\u0645\u064a\u062f\u0627\u0644\u064a\u0629 \u0627\u0644\u0641\u0636\u064a\u0629. \ud83e\udd48\n\n\ud83d\udd39 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0623\u062d\u0645\u062f \u0627\u0644\u0634\u0631\u064a\u0641 \u064a\u064f\u062d\u062f\u062b \u062b\u0648\u0631\u0629 \u0628\u062c\u0647\u0627\u0632 \u062a\u0646\u0641\u0633\u064a \u0630\u0643\u064a\u060c \u0645\u0643\u062a\u0633\u0628\u064b\u0627 \u0627\u0644\u0641\u0636\u0629. \ud83e\udd48\n\n\ud83d\udd39 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0623\u062d\u0645\u062f \u0627\u0644\u0630\u0628\u064a\u0627\u0646\u064a \u064a\u062d\u0645\u064a \u062e\u0635\u0648\u0635\u064a\u0629 \u0627\u0644\u0645\u0631\u0636\u0649 \u0628\u0633\u062a\u0631\u0629 \u063a\u0637\u0627\u0621 \u0645\u0631\u0646\u0629\u060c \u0645\u064f\u062d\u0631\u0632\u064b\u0627 \u0627\u0644\u0628\u0631\u0648\u0646\u0632. \ud83e\udd49\n\n\u0625\u0646\u062c\u0627\u0632\u0627\u062a \u062a\u0636\u0627\u0641 \u0625\u0644\u0649 \u0642\u0627\u0626\u0645\u0629 \u0627\u0644\u0646\u062c\u0627\u062d\u0627\u062a \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629 \u0639\u0644\u0649 \u0627\u0644\u0633\u0627\u062d\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064a\u0629\u060c \u0645\u0624\u0643\u062f\u0629 \u0631\u064a\u0627\u062f\u0629 \u0627\u0644\u0645\u0645\u0644\u0643\u0629 \u0641\u064a \u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631 \u0648\u0627\u0644\u0639\u0644\u0648\u0645. \ud83c\udf0d\ud83d\udc4f\n\n#\u0625\u0646\u062c\u0627\u0632\u0627\u062a_\u0633\u0639\u0648\u062f\u064a\u0629\n #\u0645\u0639\u0631\u0636_\u062c\u0646\u064a\u0641 #\u0627\u0628\u062a\u0643\u0627\u0631\n\n\n\ud83c\uddf8\ud83c\udde6\ud83d\udc9a A Global Achievement for #MeccaHealthCluster by Securing Multiple Medals at the 2024 Geneva International Invention Fair \ud83e\udd47\ud83e\udd48\ud83e\udd49\n\n\ud83d\udd39 Dr. Tawfiq Seraj innovates a leading solution for recurrent shoulder dislocation, earning a gold medal with honors. \ud83e\udd47\n\n\ud83d\udd39 Dr. Mariam Turkistani excels in using nanotechnology to directly deliver chemotherapy to cancer cells, crowned with gold. \ud83e\udd47\n\n\ud83d\udd39 Professor Ibtisam Kiriri develops a smart refrigerator for blood banks, awarded the silver medal. \ud83e\udd48\n\n\ud83d\udd39 Dr. Ahmed Al-Sharif revolutionizes with a smart respiratory device, acquiring silver. \ud83e\udd48\n\n\ud83d\udd39 Dr. Ahmed Al-Dhubyani protects patient privacy with a flexible cover vest, clinching bronze. \ud83e\udd49\n\nThese achievements add to Saudi Arabia\u2019s list of successes on the global stage, affirming the kingdom\u2019s leadership in innovation and science. \ud83c\udf0d\ud83d\udc4f\n\n#SaudiAchievements #GenevaExpo #Innovation"},"entityUrn":"urn:li:share:7187215858262237185"},"entityUrn":"urn:li:share:7187279688598249472"}}},{"createdAt":1711413600000,"insightId":"acf24160-fa96-43ac-809f-19719df673dc","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7178189116826673152","threadUrn":"urn:li:activity:7178189116826673152","reactionsCount":0,"commentsCount":8,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7178189116369420289","message":{"attributes":[],"text":"\u0628\u0633\u0645 \u0627\u0644\u0644\u0647 \u0627\u0644\u0631\u062d\u0645\u0646 \u0627\u0644\u0631\u062d\u064a\u0645 \n\n\ufd3f\u064a\u064e\u0627 \u0623\u064e\u064a\u064e\u0651\u062a\u064f\u0647\u064e\u0627 \u0627\u0644\u0646\u064e\u0651\u0641\u0652\u0633\u064f \u0627\u0644\u0652\u0645\u064f\u0637\u0652\u0645\u064e\u0626\u0650\u0646\u064e\u0651\u0629\u064f \u0627\u0631\u0652\u062c\u0650\u0639\u0650\u064a \u0625\u0650\u0644\u064e\u0649 \u0631\u064e\u0628\u0650\u0651\u0643\u0650 \u0631\u064e\u0627\u0636\u0650\u064a\u064e\u0629\u064b \u0645\u064e\u0631\u0652\u0636\u0650\u064a\u064e\u0651\u0629\u064b \u0641\u064e\u0627\u062f\u0652\u062e\u064f\u0644\u0650\u064a \u0641\u0650\u064a \u0639\u0650\u0628\u064e\u0627\u062f\u0650\u064a \u0648\u064e\u0627\u062f\u0652\u062e\u064f\u0644\u0650\u064a \u062c\u064e\u0646\u064e\u0651\u062a\u0650\u064a\ufd3e\n\n\u0628\u0642\u0644\u0648\u0628 \u0645\u0624\u0645\u0646\u0629 \u0631\u0627\u0636\u064a\u0629 \u0628\u0642\u0636\u0627\u0621 \u0627\u0644\u0644\u0647 \u0648\u0642\u062f\u0631\u0647\u060c \u0627\u0646\u062a\u0642\u0644 \u0625\u0644\u0649 \u0631\u062d\u0645\u0629 \u0627\u0644\u0644\u0647 \u062a\u0639\u0627\u0644\u0649 .\n\u0648\u0627\u0644\u062f\u064a \/ \u0639\u0628\u062f\u0627\u0644\u0639\u0632\u064a\u0632 \u0645\u0639\u0631\u0648\u0641 \u062c\u0627\u0646 \u062a\u0631\u0643\u0633\u062a\u0627\u0646\u064a \n\n\u0648\u0625\u0650\u0646\u064e\u0651\u0627 \u0644\u0650\u0644\u0651\u0647\u0650 \u0648\u064e\u0625\u0650\u0646\u064e\u0651\u0627 \u0625\u0650\u0644\u064e\u064a\u0652\u0647\u0650 \u0631\u064e\u0627\u062c\u0650\u0639\u0648\u0646\u064e\n\n\u0627\u0644\u0644\u0651\u064e\u0647\u064f\u0645\u0651\u064e \u0627\u063a\u0652\u0641\u0650\u0631\u0652 \u0644\u064e\u0647\u064f \u0648\u064e\u0627\u0631\u0652\u062d\u064e\u0645\u0652\u0647\u064f \u0648\u064e\u0639\u064e\u0627\u0641\u0650\u0647\u0650 \u0648\u064e\u0627\u0639\u0652\u0641\u064f \u0639\u064e\u0646\u0652\u0647\u064f \u0648\u064e\u0623\u064e\u0643\u0652\u0631\u0650\u0645\u0652 \u0646\u064f\u0632\u064f\u0644\u064e\u0647\u064f \u0648\u064e\u0648\u064e\u0633\u0651\u0650\u0639\u0652 \u0645\u064f\u062f\u0652\u062e\u064e\u0644\u064e\u0647\u064f \u0648\u064e\u0627\u063a\u0652\u0633\u0650\u0644\u0652\u0647\u064f \u0628\u0650\u0627\u0644\u0652\u0645\u064e\u0627\u0621\u0650 \u0648\u064e\u0627\u0644\u062b\u0651\u064e\u0644\u0652\u062c\u0650 \u0648\u064e\u0627\u0644\u0652\u0628\u064e\u0631\u064e\u062f\u0650 \u0648\u064e\u0646\u064e\u0642\u0651\u0650\u0647\u0650 \u0645\u0650\u0646\u064e \u0627\u0644\u0630\u064f\u0651\u0646\u064f\u0648\u0628\u0650 \u0648\u0627\u0644\u0652\u062e\u064e\u0637\u064e\u0627\u064a\u064e\u0627 \u0643\u064e\u0645\u064e\u0627 \u064a\u064f\u0646\u0651\u064e\u0642\u0649 \u0627\u0644\u062b\u0651\u064e\u0648\u0652\u0628\u064e \u0627\u0644\u0623\u064e\u0628\u0652\u064a\u064e\u0636\u064e \u0645\u0650\u0646\u064e \u0627\u0644\u062f\u0651\u064e\u0646\u064e\u0633\u0650."},"entityUrn":"urn:li:share:7178189116369420289"}}},{"createdAt":1715524440000,"insightId":"917eaf57-5126-4e3a-937e-951e16f44415","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7191977462661038080,7195431106593116160)","threadUrn":"urn:li:activity:7191977462661038080","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"\u0627\u0644\u0644\u0647 \u064a\u0631\u062d\u0645\u0647 \u0648\u064a\u063a\u0641\u0631\u0644\u0647 \u0648\u064a\u0633\u0643\u0646\u0647 \u0641\u0633\u064a\u062d \u062c\u0646\u0627\u062a\u0647"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7191977462661038080"}}},{"createdAt":1712026980000,"insightId":"dd627edd-c8b8-4453-821b-61382596127f","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7178189116826673152,7180761711086321664)","threadUrn":"urn:li:activity:7178189116826673152","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":31,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:6849056"}}}],"text":"Usamah Ahmed Jan \u0623\u0633\u0627\u0645\u0629 \u0623\u062d\u0645\u062f \u062c\u0627\u0646 \u062c\u0632\u0627\u0643 \u0627\u0644\u0644\u0647 \u062e\u064a\u0631"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7178189116826673152"}}},{"createdAt":1711588320000,"insightId":"24daa9e8-deb5-4c51-94c0-46508dc45493","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7178189116826673152,7178921858518401024)","threadUrn":"urn:li:activity:7178189116826673152","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":28,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:1016310290"}}}],"text":"Mohammad Abdulhakim Mousa MD \u062c\u0632\u0627\u0643 \u0627\u0644\u0644\u0647 \u062e\u064a\u0631"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7178189116826673152"}}},{"createdAt":1711588320000,"insightId":"7337b969-6a0d-40cf-80b0-7dec72827220","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7178189116826673152,7178921754474471425)","threadUrn":"urn:li:activity:7178189116826673152","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:878628110"}}}],"text":"\u0645\u062d\u0645\u062f \u0628\u0646 \u0623\u062d\u0645\u062f\u0627\u0644\u062f\u064a\u0646 \u062c\u0632\u0627\u0643 \u0627\u0644\u0644\u0647 \u0627\u0644\u0641 \u062e\u064a\u0631"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7178189116826673152"}}},{"createdAt":1711588320000,"insightId":"bb6b9fd7-7f2a-453c-a5f2-1475bb4f8ff3","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7178189116826673152,7178921943893504000)","threadUrn":"urn:li:activity:7178189116826673152","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":18,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:213539028"}}}],"text":"Sohaib I. Maghrabi \u062c\u0632\u0627\u0643 \u0627\u0644\u0644\u0647 \u062e\u064a\u0631"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7178189116826673152"}}}]}